Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Key Projections for the CAGR of the Short Read Sequencing Market Size From 2025 to 2034?

The market size for short read sequencing has seen a swift expansion in recent years. The market value is forecasted to increase from $6.66 billion in 2024 to $7.8 billion in 2025, reflecting a compound annual growth rate (CAGR) of 17.2%. The surge in the past years is linked to initiatives in genomic research, rise in the occurrence of genetic disorders, research in pharmaceutical and biotechnology, diagnostic applications, and a downward trend in sequencing costs.

In the coming years, the market size for short read sequencing is anticipated to experience a swift expansion. At a compound annual growth rate (CAGR) of 17.9%, it is expected to reach $15.06 billion by the year 2029. The predicted growth during the forecast period is primarily due to enhancement in precision medicine, a quick surge in personalized genomics, proliferation of applications in agriculture, a rapid increase in microbiome research, and growing demand from emerging markets. Significant trends during the forecast period are automation and high-throughput, cloud-based solutions, the use of artificial intelligence and machine learning, portable sequencing technologies, and the synergy of long-read sequencing.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11912&type=smp

What External and Internal Drivers Are Contributing to the Growth of theShort Read Sequencing Market?

The increase in genetic disorders is touted to boost the expansion of the short-read sequencing market. Genetic disorders, triggered by irregularities or mutations in a person’s DNA or genes, result in physical, developmental, or biochemical abnormalities affecting their health. Short-read sequencing is utilized in diagnosing genetic disorders to thoroughly analyze the genome and detect disease-linked variants. For example, a report from RARE-X, an Australian-based patient support platform confirmed that in June 2022, there were a total of 10,867 rare diseases, including both genetic and non-genetic conditions. As such, the escalating occurrences of genetic disorders are fueling the surge of the short-read sequencing market.

What Segment Types Define the Short Read Sequencing Market Structure?

The short read sequencingmarket covered in this report is segmented –

1) By Product: Instruments, Consumables, Services.

2) By Technology: Next-Generation Sequencing, Sanger Sequencing.

3) By Workflow: Pre-Sequencing, Sequencing, Data Analysis.

4) By Application: Clinical Investigation, Oncology, Reproductive Health, Consumer Genomics, Agri genomics And Forensics, HLA Typing Or Immune System Monitoring.

5) By End Users: Academic Research, Hospitals And Clinics, Clinical Research, Pharmaceutical And Biotechnology Companies.

Subsegments:

1) By Instruments: Next-Generation Sequencing (NGS) Systems, Sequencing Platforms, Library Preparation Systems

2) By Consumables: Reagents And Kits, Flow Cells, Sample Preparation Consumables

3) By Services: Sequencing Services, Data Analysis Services, Bioinformatics Services

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=11912&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Short Read Sequencing Market?

North America was the largest region in the Short Read Sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the short read sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Long-Term Trends Are Transforming the Competitive Landscape of the Short Read Sequencing Market?

The primary trend emerging in the short-read sequencing market is centred around technological progress. Significant companies in this sector are honing in on technological enhancements to refine their observation capabilities and maintain market standing. In October 2022, for instance, Pacific Biosciences Inc., an American firm renowned for its high-quality and highly accurate sequencing technologies, kick-started external beta trials of the Onso sequencing system. This system was strategically engineered to offer accurate data while making it cost-efficient. The design of the short-read platform aims to supply oncology researchers with sensitive and specific targeted sequence analysis results.

View the full report here:

https://www.thebusinessresearchcompany.com/report/short-read-sequencing-global-market-report

What Is the Definition of the Short Read Sequencing Market?

Short-read sequencing, or next-generation sequencing (NGS), is a high-throughput DNA sequencing method that generates short fragments or reads of DNA sequences. It revolutionized genomics by enabling the rapid and cost-effective analysis of entire genomes and transcriptomes.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11912

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model